Biopharmaceutical Executive Receives Prison Sentence For Insider Trading

Gadimian’s misdeeds are revealed following an internal investigation by Puma. Initially, Gadimian provides the company with redacted records of his trading history; excluding the Puma trades. In the end, however, Gadimian admits to Puma company officials that the trades took place without authorization and because of “greed.”